Skip to main content

Effect of sample type and storage conditions on Golgi membrane protein 73 stability.

Esawy MM, Shabana MA, Ahmed NH

Publication: Scand J Clin Lab Invest (2019) • Page 1-5PMID: 31495236View on PubMed

Purpose

This paper investigated glycoprotein 73 (GP73) stability at +4, -20, and -80°C in citrated plasma and serum and investigated the effects of an additional freeze-thaw cycle during frozen storage.

Conclusion

Baseline levels of GP73 were comparable in serum and citrated plasma. While GP73 levels in plasma and serum were not significantly affected by storage at 4°C for up to 72 h or at -20°C or -80°C for 6 months, GP73 declined significantly in citrated plasma and serum when stored at -20°C and thawed twice (once at 3 months and again at 6 months), but all changes were below the acceptable change limit for GP73.

Studies (1)

Purpose

This study investigated GP73 stability at +4, -20, and -80°C in citrated plasma and serum and investigated the effects of an additional freeze-thaw cycle during frozen storage. Venous blood was obtained from seven healthy patients, six patients with benign liver disease, and seven patients with newly diagnosed hepatocellular carcinoma into two Vacutainer Plus Plastic Serum Tubes and two Vacutainer Citrate Tubes. Serum was obtained by centrifugation of serum tubes at 1300 x g for 10 min and plasma by centrifugation of citrate tubes at 1500 x g for 15 min. Serum and plasma were immediately aliquoted for storage. One tube of each type was analyzed immediately and the remaining tubes were divided for storage at 4°C for 4 h, 24 h, and 72 h; at -20°C for 3 and 6 months, and at -80°C for 3 and 6 months before analysis. Additional serum and plasma aliquots were frozen at -20°C and -80°C, thawed in cold water, stored at room temperature for 30 min, and then refrozen for an additional 3 months before analysis. GP73 levels were measured using an ELISA. As the data was not normally distributed, data was analyzed using the Wilcoxon Signed Rank Test and Mann–Whitney U test and changes were compared to the acceptable change limit for GP73 calculated according to ISO 5725-6 (6.1%).

Summary of Findings

Baseline levels of GP73 were comparable in serum and citrated plasma. While GP73 levels in plasma and serum were not significantly affected by storage at 4°C for up to 72 h or at -20°C or -80°C for 6 months, GP73 declined by 5.2% in serum (P=0.03) and 2.8% in citrated plasma (P=0.004) when stored at -20°C and thawed twice (once at 3 months and again at 6 months) but all changes were below the acceptable change limit for GP73.

 

  • Biospecimens

    FluidBlood
    FluidPlasma
    FluidSerum
  • Preservation Types

    FrozenNone (Fresh)
  • Diagnoses

    NeoplasticBenign
    NeoplasticCarcinoma
    Normal
  • Platforms

    GlycoproteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionType of collection container/solution
    Citrate tube
    Serum tube
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum
    StorageFreeze/thaw cycling
    0 cycles
    1 cycle
    2 cycles
    StorageStorage duration
    0 h
    24 h
    3 months
    4 h
    6 months
    72 h
    StorageStorage temperature
    -20°C
    -80°C
    4°C
    ELISA SpecificTargeted peptide/protein
    GP73